155 related articles for article (PubMed ID: 38495245)
1. Association of Insulin-like Growth Factor-1 and Neurofilament Light Chain in Patients with Progressive Supranuclear Palsy.
Dey S; Yelamanchi R; Mullapudi T; Holla VV; Kamble N; Mahale RR; Sathyaprabha TN; Pal PK; Debnath M; Yadav R
Ann Indian Acad Neurol; 2024; 27(1):40-45. PubMed ID: 38495245
[TBL] [Abstract][Full Text] [Related]
2. Serum neurofilament light chain in progressive supranuclear palsy.
Donker Kaat L; Meeter LH; Chiu WZ; Melhem S; Boon AJW; Blennow K; Zetterberg H; van Swieten JC
Parkinsonism Relat Disord; 2018 Nov; 56():98-101. PubMed ID: 29937097
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament Light Chain Levels in Frontotemporal Dementia and Progressive Supranuclear Palsy: A Systematic Review.
Bendstrup N; Hejl AM; Salvesen L
J Alzheimers Dis; 2022; 87(1):131-140. PubMed ID: 35275542
[TBL] [Abstract][Full Text] [Related]
4. Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.
Rojas JC; Karydas A; Bang J; Tsai RM; Blennow K; Liman V; Kramer JH; Rosen H; Miller BL; Zetterberg H; Boxer AL
Ann Clin Transl Neurol; 2016 Mar; 3(3):216-25. PubMed ID: 27042681
[TBL] [Abstract][Full Text] [Related]
5. Performance of [
Oliveira Hauer K; Pawlik D; Leuzy A; Janelidze S; Hall S; Hansson O; Smith R
Parkinsonism Relat Disord; 2023 Jan; 106():105226. PubMed ID: 36442367
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
[TBL] [Abstract][Full Text] [Related]
7. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
9. CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.
Rojas JC; Bang J; Lobach IV; Tsai RM; Rabinovici GD; Miller BL; Boxer AL;
Neurology; 2018 Jan; 90(4):e273-e281. PubMed ID: 29282336
[TBL] [Abstract][Full Text] [Related]
10. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
[TBL] [Abstract][Full Text] [Related]
11. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
Mangesius S; Mariotto S; Ferrari S; Pereverzyev S; Lerchner H; Haider L; Gizewski ER; Wenning G; Seppi K; Reindl M; Poewe W
Parkinsonism Relat Disord; 2020 Aug; 77():57-63. PubMed ID: 32622301
[TBL] [Abstract][Full Text] [Related]
12. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
14. Blood neurofilament light chain in Parkinson disease and atypical parkinsonisms: A protocol for systematic review and meta-analysis.
Wang H; Wang W; Shi H; Han L; Pan P
Medicine (Baltimore); 2020 Oct; 99(40):e21871. PubMed ID: 33019386
[TBL] [Abstract][Full Text] [Related]
15. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
Nonaka W; Takata T; Iwama H; Komatsubara S; Kobara H; Kamada M; Deguchi K; Touge T; Miyamoto O; Nakamura T; Itano T; Masaki T
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039873
[TBL] [Abstract][Full Text] [Related]
16. Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy.
Huang SY; Chen SF; Cui M; Zhao M; Shen XN; Guo Y; Zhang YR; Zhang W; Wang HF; Huang YY; Cheng W; Zuo CT; Dong Q; Yu JT
Mov Disord; 2023 Apr; 38(4):676-682. PubMed ID: 36781585
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
Wang SY; Chen W; Xu W; Li JQ; Hou XH; Ou YN; Yu JT; Tan L
J Alzheimers Dis; 2019; 72(4):1353-1361. PubMed ID: 31744001
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes.
Quadalti C; Calandra-Buonaura G; Baiardi S; Mastrangelo A; Rossi M; Zenesini C; Giannini G; Candelise N; Sambati L; Polischi B; Plazzi G; Capellari S; Cortelli P; Parchi P
NPJ Parkinsons Dis; 2021 Oct; 7(1):93. PubMed ID: 34635674
[TBL] [Abstract][Full Text] [Related]
20. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
